Whitepapers/App Notes/Posters

Whitepaper: Recombinant factor C: new Ph. Eur. Chapter 2.6.32

Posted: 14 December 2020 | | No comments yet

Pharmaceutical and medical device manufacturers can now use the compendial chapter 2.6.32.

Test for bacterial endotoxins using recombinant factor C for their bacterial endotoxin testing (BET) without needing to validate the method. On 1 January 2021, the new general chapter 2.6.32. and
revised general chapter 5.1.10. Guidelines for using the test for bacterial endotoxins, will come into effect.











    To read this whitepaper in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of bioMérieux

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Send this to a friend